Dermolab Pharma Ltd is a privately-owned company with a compelling focus on innovation, transparency, quality, and flexibility in the design, manufacture, and packaging of cosmetic, pharmaceutical, and natural health products. Established in 1985, the company has built an unparalleled reputation for delivering high-quality, personalized service, fast turnaround, consultant service, and competitive prices to its customers in North America and Europe.
The company's state-of-the-art R&D laboratory specializes in formulating and custom-manufacturing innovative cosmetic products in large and small quantities. Dermolab Pharma's ability to harness the most advanced, natural, and powerful ingredients is evident in its product offerings. Furthermore, its versatile equipment allows for packaging a wide range of liquid and semi-liquid products in various formats, including jars, bottles, spray pumps, tubes, and glass vials.
Dermolab Pharma operates in the Enterprise Software, Health Care, and Manufacturing industries, positioning itself at the intersection of technology, healthcare, and production. Despite the absence of specific details regarding its headquarters and recent investment activities, the company's track record and dedication to technological advancement make it an intriguing prospect for potential investors seeking exposure to the evolving landscape of cosmetic and pharmaceutical manufacturing.
Overall, Dermolab Pharma's steadfast commitment to delivering innovative solutions while upholding uncompromising standards of quality and flexibility makes it a standout player in its industry.There is no investment information
No recent news or press coverage available for Dermolab Pharma Ltd.